These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16116815)

  • 1. [Pharmacotherapy for degenerative dementias].
    Maloteaux JM
    Bull Mem Acad R Med Belg; 2005; 160(1-2):109-17; discussion 118-22. PubMed ID: 16116815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologically activated therapeutics for neuroprotection.
    Lipton SA
    Nat Rev Neurosci; 2007 Oct; 8(10):803-8. PubMed ID: 17882256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of dementia: anything new?
    Machado JC; Caramelli P
    Curr Opin Psychiatry; 2006 Nov; 19(6):575-80. PubMed ID: 17012934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When should drug treatment be started for people with dementia?
    Singh B; O'Brien JT
    Maturitas; 2009 Mar; 62(3):230-4. PubMed ID: 19201114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of memantine in the treatment of Alzheimer's disease].
    Molinuevo Guix JL; Lladó Plarrumaní A
    Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controversies about new drugs for the treatment of dementia. An unfavourable view].
    Guardado-Santervás P
    Rev Neurol; 2001 Jan 16-31; 32(2):172-5. PubMed ID: 11299482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alzheimer's disease: therapeutic perspectives].
    Dubois B; De Souza L; Allali G; Kalafat M; Sarazin M
    Bull Acad Natl Med; 2008 Feb; 192(2):333-42; discussion 343-4. PubMed ID: 18819687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.
    Muir KW
    Curr Opin Pharmacol; 2006 Feb; 6(1):53-60. PubMed ID: 16359918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current issues in dementia pharmacotherapy.
    Daiello LA
    Am J Manag Care; 2007 Dec; 13 Suppl 8():S198-202. PubMed ID: 18095783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
    Cummings JL; Mackell J; Kaufer D
    Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An individualized approach to treatment for alzheimer's disease, pick's disease, and other dementias.
    Lippa CF
    Am J Alzheimers Dis Other Demen; 2006; 21(5):354-9. PubMed ID: 17062555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-dementia drugs: myth, hype or reality?
    Allain H; Bentué-Ferrer D
    Curr Opin Neurol; 2003 Dec; 16 Suppl 2():S23-7. PubMed ID: 15129847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2007 Feb; 5(54):9-14. PubMed ID: 17261969
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological treatment of non-Alzheimer dementias.
    Arlt S; Jahn H
    Curr Opin Psychiatry; 2006 Nov; 19(6):642-8. PubMed ID: 17012946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A; Alfaro V
    Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review.
    Leroi I; Collins D; Marsh L
    J Neurol Sci; 2006 Oct; 248(1-2):104-14. PubMed ID: 16806271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.